Skip to main content
Premium Trial:

Request an Annual Quote

BioMicro Systems Closes Series B Funding, Plans to Broaden Product Line

NEW YORK (GenomeWeb News) - BioMicro Systems said today it has closed a round of Series B financing with investors vSpring, Nanostart, and Staley Capital Advisors.
 
BioMicro, which markets the MAUI hybridization product line, did not disclose the amount of funding it received in this round, but said the new investments bring the total it has raised since inception to $10 million.
 
Company CEO Michael Feldman said BioMicro plans to use the money to "broaden our product portfolio to include Kreatech reagents, Arrayjet microarrayers and soon-to-be-announced new products."

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.